CHAPLIN PAUL has a total of 13 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BARBER GLEN N, MESOBLAST INTERNAT SARL and STEM CELL THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Measuring microorganism processes | |
#6 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Chaplin Paul | 13 |
#2 | Howley Paul | 5 |
#3 | Meisinger-Henschel Christine | 5 |
#4 | Mateo Luis | 2 |
#5 | Heller Karl | 2 |
#6 | Felder Eva | 2 |
#7 | Rathe Ingmar | 2 |
#8 | Nichols Richard | 1 |
Publication | Filing date | Title |
---|---|---|
US2011052627A1 | Recombinant modified vaccinia virus measles vaccine | |
US2010011451A1 | Phenotypic and genotypic differences of mva strains |